Source:http://linkedlifedata.com/resource/pubmed/id/15134894
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2004-5-11
|
pubmed:abstractText |
Leukemic dendritic cells (DC) were induced from the peripheral blood (PB) or bone marrow (BM) of leukemia patients by culture with (i) GM-CSF + IL-3 (neutral condition); (ii) GM-CSF + IL-3 + IL-12 + IFN-gamma (type 1-condition); or (iii) GM-CSF + IL-3 + IL-4 (type 2-condition). Although leukemic cells rapidly differentiated into adhesive leukemic DC in all culture conditions, type1-conditions were the most suitable for inducing leukemic DC expressing high levels of HLA and costimulatory molecules. Addition of IL-2 after 2 days of culture induced a preferential growth of minor T cell populations interacting with leukemic DC. In particular, IFN-gamma-producing CD4+ Th1 cells were efficiently expanded in type 1 culture conditions but nor in neutral or type 2-conditions. However, CD4+ T cells expanded in neutral conditions showed Th1-like functions if they were pulsed with IFN-gamma for 2 days before harvest. Such Th1 cells produced IFN-gamma and exhibited cytotoxicity in response to autologous leukemia cells. We further demonstrated that IFN-gamma production of leukemia-specific Th1 cells was blocked by anti-HLA-DR mAb. Thus, we established a novel culture system for inducing leukemia-specific Th1 cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0165-2478
|
pubmed:author |
pubmed-author:AibaSetsuyaS,
pubmed-author:ChamotoKenjiK,
pubmed-author:FujimuraTakuT,
pubmed-author:ImamuraMasahiroM,
pubmed-author:KodaToshiakiT,
pubmed-author:NishimuraTakashiT,
pubmed-author:SatoTakeshiT,
pubmed-author:TagamiHachiroH,
pubmed-author:TanakaJunjiJ,
pubmed-author:TogashiYujiY,
pubmed-author:TsujiTakemasaT,
pubmed-author:YokouchiHiroshiH
|
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
93
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
17-25
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15134894-Adult,
pubmed-meshheading:15134894-Aged,
pubmed-meshheading:15134894-Bone Marrow Cells,
pubmed-meshheading:15134894-Dendritic Cells,
pubmed-meshheading:15134894-Genes, abl,
pubmed-meshheading:15134894-Histocompatibility Antigens Class II,
pubmed-meshheading:15134894-Humans,
pubmed-meshheading:15134894-In Situ Hybridization, Fluorescence,
pubmed-meshheading:15134894-Interferon-gamma,
pubmed-meshheading:15134894-Leukemia,
pubmed-meshheading:15134894-Middle Aged,
pubmed-meshheading:15134894-Th1 Cells
|
pubmed:year |
2004
|
pubmed:articleTitle |
Generation of leukemia-specific T-helper type 1 cells applicable to human leukemia cell-therapy.
|
pubmed:affiliation |
Division of Immunoregulation, Institute for Genetic Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo 060-0815, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|